首页> 外文期刊>Diabetology and Metabolic Syndrome >The multiple functions of the endocannabinoid system: a focus on the regulation of food intake
【24h】

The multiple functions of the endocannabinoid system: a focus on the regulation of food intake

机译:内源性大麻素系统的多种功能:着重于食物摄取的调节

获取原文
           

摘要

Background Cannabis sativa (also known as marijuana) has been cultivated by man for more than 5,000 years. However, there was a rise in its use in the 20th century for recreational, religious or spiritual, and medicinal purposes. The main psychoactive constituent of cannabis, whose structure was identified in the 1960's, is Δ9-tetrahydrocannabinol. On the other hand, the discovery of cannabinoid receptors and their endogenous agonists took place only very recently. In fact, the first cannabinoid receptor (CB1) was cloned in 1990, followed 3 years later by the characterization of a second cannabinoid receptor (CB2). Since the 19th century, the use of cannabis has been reported to stimulate appetite and increase the consumption of sweet and tasty food, sometimes resulting in significant weight gain. The recent description of the endocannabinoid system, not only in the central nervous system but also in peripheral tissues, points to its involvement in the regulation of appetite, food intake and energy metabolism. Consequently, the pharmacological modulation of the over-activity of this system could be useful in the treatment of the metabolic syndrome. Conclusions The endocannabinoid system has important physiological functions not only in the central nervous system but also in peripheral tissues. The activation of central CB1 receptors, particularly in hypothalamic nuclei and in the limbic system, is involved in the regulation of feeding behavior, and especially in the control of the intake of palatable food. In the periphery, cannabinoid receptors are present in adipocytes, skeletal muscle, gastrointestinal tract and liver, modulating energy metabolism.
机译:背景技术大麻已经被人类种植了五千多年。但是,在20世纪,将其用于娱乐,宗教或精神以及医学目的的用途有所增加。大麻的主要精神活性成分是Δ9-四氢大麻酚,其结构在1960年代得到鉴定。另一方面,大麻素受体及其内源性激动剂的发现仅在最近才发生。实际上,第一个大麻素受体(CB1)于1990年被克隆,三年后第二个大麻素受体(CB2)的特性被克隆。自19世纪以来,已有报道使用大麻来刺激食欲并增加甜食和美味食品的消费,有时会导致体重明显增加。最近对内源性大麻素系统的描述,不仅在中枢神经系统中,而且在周围组织中,都表明其参与食欲,食物摄入和能量代谢的调节。因此,该系统过度活跃的药理学调节可用于代谢综合征的治疗。结论内源性大麻素系统不仅在中枢神经系统中而且在周围组织中都具有重要的生理功能。中央CB1受体的激活,特别是在下丘脑核和边缘系统中的激活,参与了进食行为的调节,尤其是对可口食物摄入的控制。在外围,大麻素受体存在于脂肪细胞,骨骼肌,胃肠道和肝脏中,调节能量代谢。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号